BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 20400365)

  • 41. The transcription factor FOXM1 regulates the balance between proliferation and aberrant differentiation in head and neck squamous cell carcinoma.
    Roh V; Hiou-Feige A; Misetic V; Rivals JP; Sponarova J; Teh MT; Ferreira Lopes S; Truan Z; Mermod M; Monnier Y; Hess J; Tolstonog GV; Simon C
    J Pathol; 2020 Jan; 250(1):107-119. PubMed ID: 31465124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of CEP55, PLK1 and FOXM1 expression in patients with bladder cancer in comparison with healthy individuals.
    Seyedabadi S; Saidijam M; Najafi R; Mousavi-Bahar SH; Jafari M; MohammadGanji S; Mahdavinezhad A
    Cancer Invest; 2018; 36(8):407-414. PubMed ID: 30277841
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases.
    Cortesina G; Martone T; Galeazzi E; Olivero M; De Stefani A; Bussi M; Valente G; Comoglio PM; Di Renzo MF
    Int J Cancer; 2000 May; 89(3):286-92. PubMed ID: 10861506
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of molecular targets for immunotherapy of patients with head and neck squamous cell carcinoma.
    Dasgupta S; Tripathi PK; Qin H; Bhattacharya-Chatterjee M; Valentino J; Chatterjee SK
    Oral Oncol; 2006 Mar; 42(3):306-16. PubMed ID: 16321566
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of the antileukoprotease SLPI in smoking-induced human papillomavirus-independent head and neck squamous cell carcinomas.
    Quabius ES; Möller P; Haag J; Pfannenschmidt S; Hedderich J; Görögh T; Röcken C; Hoffmann M
    Int J Cancer; 2014 Mar; 134(6):1323-34. PubMed ID: 23996702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene.
    Liu CJ; Shen WG; Peng SY; Cheng HW; Kao SY; Lin SC; Chang KW
    Int J Cancer; 2014 Feb; 134(4):811-21. PubMed ID: 23824713
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck.
    Sauter ER; Nesbit M; Watson JC; Klein-Szanto A; Litwin S; Herlyn M
    Clin Cancer Res; 1999 Apr; 5(4):775-82. PubMed ID: 10213212
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aberrant expression of serum amyloid A in head and neck squamous cell carcinoma.
    Shinriki S; Ueda M; Ota K; Nakamura M; Kudo M; Ibusuki M; Kim J; Yoshitake Y; Fukuma D; Jono H; Kuratsu J; Shinohara M; Ando Y
    J Oral Pathol Med; 2010 Jan; 39(1):41-7. PubMed ID: 19453393
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased Expression of LAMTOR5 Predicts Poor Prognosis and Is Associated with Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma.
    Yang QC; Wu CC; Cao LY; Xiao Y; Li H; Liu B; Sun ZJ
    Int J Med Sci; 2019; 16(6):783-792. PubMed ID: 31337951
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors.
    Franzmann EJ; Schroeder GL; Goodwin WJ; Weed DT; Fisher P; Lokeshwar VB
    Int J Cancer; 2003 Sep; 106(3):438-45. PubMed ID: 12845686
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number.
    Canel M; Secades P; Rodrigo JP; Cabanillas R; Herrero A; Suarez C; Chiara MD
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3272-9. PubMed ID: 16740747
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of CD44v6 isoforms in head-and-neck squamous-cell carcinoma.
    van Hal NL; van Dongen GA; Stigter-van Walsum M; Snow GB; Brakenhoff RH
    Int J Cancer; 1999 Sep; 82(6):837-45. PubMed ID: 10446451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nuclear localization of heme oxygenase-1 is associated with tumor progression of head and neck squamous cell carcinomas.
    Gandini NA; Fermento ME; Salomón DG; Blasco J; Patel V; Gutkind JS; Molinolo AA; Facchinetti MM; Curino AC
    Exp Mol Pathol; 2012 Oct; 93(2):237-45. PubMed ID: 22580187
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exploiting FOXM1-orchestrated molecular network for early squamous cell carcinoma diagnosis and prognosis.
    Teh MT; Hutchison IL; Costea DE; Neppelberg E; Liavaag PG; Purdie K; Harwood C; Wan H; Odell EW; Hackshaw A; Waseem A
    Int J Cancer; 2013 May; 132(9):2095-106. PubMed ID: 23034676
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transgenic mice expressing constitutively active Akt in oral epithelium validate KLFA as a potential biomarker of head and neck squamous cell carcinoma.
    Moral M; Segrelles C; Martínez-Cruz AB; Lorz C; Santos M; García-Escudero R; Lu J; Buitrago A; Costa C; Saiz C; Ariza JM; Dueñas M; Rodriguez-Peralto JL; Martinez-Tello FJ; Rodriguez-Pinilla M; Sanchez-Cespedes M; Digiovanni J; Paramio JM
    In Vivo; 2009; 23(5):653-60. PubMed ID: 19779097
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lentivirus-mediated knockdown of CEP55 suppresses cell proliferation of breast cancer cells.
    Wang Y; Jin T; Dai X; Xu J
    Biosci Trends; 2016 Feb; 10(1):67-73. PubMed ID: 26902787
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression, association with clinicopathological features and prognostic potential of CEP55, p-Akt, FoxM1 and MMP-2 in astrocytoma.
    Nie S; Lou L; Wang J; Cui J; Wu W; Zhang Q; Liu Y; Su L; Chang Y; Guo W; Shen H; Xing L; Li Y
    Oncol Lett; 2020 Aug; 20(2):1685-1694. PubMed ID: 32724411
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis.
    Yang K; Zhang S; Zhang D; Tao Q; Zhang T; Liu G; Liu X; Zhao T
    Int J Clin Oncol; 2019 Sep; 24(9):1030-1041. PubMed ID: 30937621
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LOXL4 is a selectively expressed candidate diagnostic antigen in head and neck cancer.
    Weise JB; Rudolph P; Heiser A; Kruse ML; Hedderich J; Cordes C; Hoffmann M; Brant O; Ambrosch P; Csiszar K; Görögh T
    Eur J Cancer; 2008 Jun; 44(9):1323-31. PubMed ID: 18499440
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FOXM1 drives HPV+ HNSCC sensitivity to WEE1 inhibition.
    Diab A; Gem H; Swanger J; Kim HY; Smith K; Zou G; Raju S; Kao M; Fitzgibbon M; Loeb KR; Rodriguez CP; Méndez E; Galloway DA; Sidorova JM; Clurman BE
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28287-28296. PubMed ID: 33093209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.